These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12239745)

  • 1. Methods for a public health response to birth defects clusters.
    Williams LJ; Honein MA; Rasmussen SA
    Teratology; 2002; 66 Suppl 1():S50-8. PubMed ID: 12239745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Birth Defects Cluster Study: a national approach to birth defects cluster investigations.
    Kucik JE; Bitsko RH; Williams L; Lazarus C; Jarman DW; Correa A
    Birth Defects Res A Clin Mol Teratol; 2008 Nov; 82(11):805-11. PubMed ID: 18985695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodological issues in setting up a surveillance system for birth defects in India.
    Suresh S; Thangavel G; Sujatha J; Indrani S
    Natl Med J India; 2005; 18(5):259-62. PubMed ID: 16433142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guidelines for investigating clusters of health events].
    Epidemiol Prev; 1995 Jun; 19(63):206-18. PubMed ID: 7641863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of DNA sample collection into a multi-site birth defects case-control study.
    Rasmussen SA; Lammer EJ; Shaw GM; Finnell RH; McGehee RE; Gallagher M; Romitti PA; Murray JC;
    Teratology; 2002 Oct; 66(4):177-84. PubMed ID: 12353214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics that predict locating and interviewing mothers identified by a state birth defects registry and vital records.
    Gilboa SM; Mendola P; Olshan AF; Savitz DA; Herring AH; Loomis D; Langlois PH; Keating K
    Birth Defects Res A Clin Mol Teratol; 2006 Jan; 76(1):60-5. PubMed ID: 16397888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of family history reports of major birth defects as a public health strategy.
    Romitti PA
    Pediatrics; 2007 Sep; 120 Suppl 2():S71-7. PubMed ID: 17767008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Birth defects interstate data exchange: a battle worth fighting?
    Cassell C; Mai C; Rickard R
    Birth Defects Res A Clin Mol Teratol; 2007 Nov; 79(11):806-10. PubMed ID: 17990342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geocoding capacity of birth defects surveillance programs: results from the National Birth Defects Prevention Network Geocoding Survey.
    Wang Y; O'Leary LA; Rickard RS; Mason CA;
    J Registry Manag; 2010; 37(1):22-6. PubMed ID: 20795566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion of early fetal deaths in a birth defects surveillance system.
    Forrester MB; Merz RD
    Teratology; 2001; 64 Suppl 1():S20-5. PubMed ID: 11745840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving case ascertainment of a population-based birth defects registry in New York State using hospital discharge data.
    Wang Y; Sharpe-Stimac M; Cross PK; Druschel CM; Hwang SA
    Birth Defects Res A Clin Mol Teratol; 2005 Oct; 73(10):663-8. PubMed ID: 16240383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Registry to referral: using birth defects registries to refer infants and toddlers for early intervention services.
    Farel AM; Meyer RE; Hicken M; Edmonds LD
    Birth Defects Res A Clin Mol Teratol; 2003 Sep; 67(9):647-50. PubMed ID: 14703788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Birth defects ascertainment in the Philippines.
    Padilla- CD; Cutiongco EM; Sia JM
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():239-43. PubMed ID: 15906745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collection, use, and protection of population-based birth defects surveillance data in the united states.
    Mai CT; Law DJ; Mason CA; McDowell BD; Meyer RE; Musa D;
    Birth Defects Res A Clin Mol Teratol; 2007 Dec; 79(12):811-4. PubMed ID: 18064713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for case classification for the National Birth Defects Prevention Study.
    Rasmussen SA; Olney RS; Holmes LB; Lin AE; Keppler-Noreuil KM; Moore CA;
    Birth Defects Res A Clin Mol Teratol; 2003 Mar; 67(3):193-201. PubMed ID: 12797461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Random error and undercounting in birth defects surveillance data: implications for inference.
    Correa-Villaseñor A; Satten GA; Rolka H; Langlois P; Devine O
    Birth Defects Res A Clin Mol Teratol; 2003 Sep; 67(9):610-6. PubMed ID: 14703782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sources of variability in birth defects prevalence rates.
    Hobbs CA; Hopkins SE; Simmons CJ
    Teratology; 2001; 64 Suppl 1():S8-S13. PubMed ID: 11745838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved national prevalence estimates for 18 selected major birth defects--United States, 1999-2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Jan; 54(51):1301-5. PubMed ID: 16397457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hungarian congenital malformation monitoring system.
    Czeizel A
    Acta Paediatr Acad Sci Hung; 1978; 19(3):225-38. PubMed ID: 735805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.